Selected research
Industry Research
Drug Eluting Beads Industry Research Report 2026
Market perspective
The global Drug Eluting Beads market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Drug Eluting Beads is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Drug Eluting Beads is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Drug Eluting Beads is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Drug Eluting Beads include Medtronic, Terumo, Surefire Medical, Merit Medical Systems, Merit Medical Systems, CeloNova BioSciences, BTG International, Boston Scientific and Biocompatibles, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Drug Eluting Beads market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug Eluting Beads Market by Company
Medtronic
Terumo
Surefire Medical
Merit Medical Systems
Merit Medical Systems
CeloNova BioSciences
BTG International
Boston Scientific
Biocompatibles
ABK Biomedical
Drug Eluting Beads Segment by Type
LC Beads
Quadra Sphere
Oncozene Beads
Others
Drug Eluting Beads Segment by Application
Specialized Clinics
Hospitals
Research Centers
Ambulatory Surgical Centers
Drug Eluting Beads Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Eluting Beads market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Eluting Beads and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Eluting Beads.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Drug Eluting Beads manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Drug Eluting Beads by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Drug Eluting Beads in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- LC Beads
- Quadra Sphere
- Oncozene Beads
- Others
Applications
- Specialized Clinics
- Hospitals
- Research Centers
- Ambulatory Surgical Centers
Companies covered
- Medtronic
- Terumo
- Surefire Medical
- Merit Medical Systems
- Merit Medical Systems
- CeloNova BioSciences
- BTG International
- Boston Scientific
- Biocompatibles
- ABK Biomedical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Drug Eluting Beads Market Size (2021-2032)
- 2.2.2 Global Drug Eluting Beads Sales (2021-2032)
- 2.2.3 Global Drug Eluting Beads Market Average Price (2021-2032)
- 2.3 Drug Eluting Beads by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 LC Beads
- 2.3.3 Quadra Sphere
- 2.3.4 Oncozene Beads
- 2.3.5 Others
- 2.4 Drug Eluting Beads by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Specialized Clinics
- 2.4.3 Hospitals
- 2.4.4 Research Centers
- 2.4.5 Ambulatory Surgical Centers
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Drug Eluting Beads Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Drug Eluting Beads Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Drug Eluting Beads Revenue of Manufacturers (2021-2026)
- 3.4 Global Drug Eluting Beads Average Price by Manufacturers (2021-2026)
- 3.5 Global Drug Eluting Beads Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Drug Eluting Beads, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Drug Eluting Beads, Product Type & Application
- 3.8 Global Manufacturers of Drug Eluting Beads, Established Date
- 3.9 Global Drug Eluting Beads Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Medtronic
- 4.1.1 Medtronic Company Information
- 4.1.2 Medtronic Business Overview
- 4.1.3 Medtronic Drug Eluting Beads Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Medtronic Drug Eluting Beads Product Portfolio
- 4.1.5 Medtronic Recent Developments
- 4.2 Terumo
- 4.2.1 Terumo Company Information
- 4.2.2 Terumo Business Overview
- 4.2.3 Terumo Drug Eluting Beads Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Terumo Drug Eluting Beads Product Portfolio
- 4.2.5 Terumo Recent Developments
- 4.3 Surefire Medical
- 4.3.1 Surefire Medical Company Information
- 4.3.2 Surefire Medical Business Overview
- 4.3.3 Surefire Medical Drug Eluting Beads Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Surefire Medical Drug Eluting Beads Product Portfolio
- 4.3.5 Surefire Medical Recent Developments
- 4.4 Merit Medical Systems
- 4.4.1 Merit Medical Systems Company Information
- 4.4.2 Merit Medical Systems Business Overview
- 4.4.3 Merit Medical Systems Drug Eluting Beads Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merit Medical Systems Drug Eluting Beads Product Portfolio
- 4.4.5 Merit Medical Systems Recent Developments
- 4.5 Merit Medical Systems
- 4.5.1 Merit Medical Systems Company Information
- 4.5.2 Merit Medical Systems Business Overview
- 4.5.3 Merit Medical Systems Drug Eluting Beads Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Merit Medical Systems Drug Eluting Beads Product Portfolio
- 4.5.5 Merit Medical Systems Recent Developments
- 4.6 CeloNova BioSciences
- 4.6.1 CeloNova BioSciences Company Information
- 4.6.2 CeloNova BioSciences Business Overview
- 4.6.3 CeloNova BioSciences Drug Eluting Beads Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 CeloNova BioSciences Drug Eluting Beads Product Portfolio
- 4.6.5 CeloNova BioSciences Recent Developments
- 4.7 BTG International
- 4.7.1 BTG International Company Information
- 4.7.2 BTG International Business Overview
- 4.7.3 BTG International Drug Eluting Beads Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 BTG International Drug Eluting Beads Product Portfolio
- 4.7.5 BTG International Recent Developments
- 4.8 Boston Scientific
- 4.8.1 Boston Scientific Company Information
- 4.8.2 Boston Scientific Business Overview
- 4.8.3 Boston Scientific Drug Eluting Beads Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Boston Scientific Drug Eluting Beads Product Portfolio
- 4.8.5 Boston Scientific Recent Developments
- 4.9 Biocompatibles
- 4.9.1 Biocompatibles Company Information
- 4.9.2 Biocompatibles Business Overview
- 4.9.3 Biocompatibles Drug Eluting Beads Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Biocompatibles Drug Eluting Beads Product Portfolio
- 4.9.5 Biocompatibles Recent Developments
- 4.10 ABK Biomedical
- 4.10.1 ABK Biomedical Company Information
- 4.10.2 ABK Biomedical Business Overview
- 4.10.3 ABK Biomedical Drug Eluting Beads Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 ABK Biomedical Drug Eluting Beads Product Portfolio
- 4.10.5 ABK Biomedical Recent Developments
5 Global Drug Eluting Beads Market Scenario by Region
- 5.1 Global Drug Eluting Beads Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Drug Eluting Beads Sales by Region: 2021-2032
- 5.2.1 Global Drug Eluting Beads Sales by Region: 2021-2026
- 5.2.2 Global Drug Eluting Beads Sales by Region: 2027-2032
- 5.3 Global Drug Eluting Beads Revenue by Region: 2021-2032
- 5.3.1 Global Drug Eluting Beads Revenue by Region: 2021-2026
- 5.3.2 Global Drug Eluting Beads Revenue by Region: 2027-2032
- 5.4 North America Drug Eluting Beads Market Facts & Figures by Country
- 5.4.1 North America Drug Eluting Beads Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Drug Eluting Beads Sales by Country (2021-2032)
- 5.4.3 North America Drug Eluting Beads Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Drug Eluting Beads Market Facts & Figures by Country
- 5.5.1 Europe Drug Eluting Beads Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Drug Eluting Beads Sales by Country (2021-2032)
- 5.5.3 Europe Drug Eluting Beads Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Drug Eluting Beads Market Facts & Figures by Country
- 5.6.1 Asia Pacific Drug Eluting Beads Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Drug Eluting Beads Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Drug Eluting Beads Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Drug Eluting Beads Market Facts & Figures by Country
- 5.7.1 South America Drug Eluting Beads Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Drug Eluting Beads Sales by Country (2021-2032)
- 5.7.3 South America Drug Eluting Beads Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Drug Eluting Beads Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Drug Eluting Beads Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Drug Eluting Beads Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Drug Eluting Beads Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Drug Eluting Beads Sales by Type (2021-2032)
- 6.1.1 Global Drug Eluting Beads Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Drug Eluting Beads Sales Market Share by Type (2021-2032)
- 6.2 Global Drug Eluting Beads Revenue by Type (2021-2032)
- 6.2.1 Global Drug Eluting Beads Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Drug Eluting Beads Revenue Market Share by Type (2021-2032)
- 6.3 Global Drug Eluting Beads Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Drug Eluting Beads Sales by Application (2021-2032)
- 7.1.1 Global Drug Eluting Beads Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Drug Eluting Beads Sales Market Share by Application (2021-2032)
- 7.2 Global Drug Eluting Beads Revenue by Application (2021-2032)
- 7.2.1 Global Drug Eluting Beads Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Drug Eluting Beads Revenue Market Share by Application (2021-2032)
- 7.3 Global Drug Eluting Beads Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Drug Eluting Beads Value Chain Analysis
- 8.1.1 Drug Eluting Beads Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Drug Eluting Beads Production Mode & Process
- 8.2 Drug Eluting Beads Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Drug Eluting Beads Distributors
- 8.2.3 Drug Eluting Beads Customers
9 Global Drug Eluting Beads Analyzing Market Dynamics
- 9.1 Drug Eluting Beads Industry Trends
- 9.2 Drug Eluting Beads Industry Drivers
- 9.3 Drug Eluting Beads Industry Opportunities and Challenges
- 9.4 Drug Eluting Beads Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst